AKT1 and neoplasm: Additionally, PI3K/AKT/mTOR signaling alters the immune landscape by promoting the recruitment of immunosuppressive cells, such as regulatory T cells (Tregs), which further dampen antitumor immunity and facilitate tumor progression [37].